Tuesday, June 16, 4:00 – 5:30 am
Auditorium Lulli

Chairs: Eric Van Cutsem – Anneli Elme – Mike Gibson

1. ESMO standards of care: equal to other countries in the world? – Radka L. Obermannová (Czech Republic) 
2. Biomarker in advanced esophageal cancers: what do we need to know. – Magali Svrcek (France) 
3. Eastern Perspectives on Esophageal Cancer – Exploring Regional Differences in Clinical Characteristics and Treatment Strategies, with a Focus on ESD. – Hwoon-Yong Jung (Korea)
4. Molecular response prediction in esophageal squamous cell carcinomas: results of the EORTC/SAKK POWER project. – Alexander Siebenhuener 
5. IO tailored personalized medicine included side effects, drug holidays and maintenance. – Ian Chau (UK) 
6. Oligometastatic disease: recommendations or studies ahead? – Şuayib Yalçın 
7. Gender medicine: already prime-time? – Anna Wagner 
8. ASCO 2026: important news and approvals ahead? TBD 
9. Dr. Gibson’s talk on oncology. – Mike Gibson 
10. Liquid biopsies and Artificial intelligence (AI) as a practical decision support tool for oncologists: ready for prime time? – Ajay Goel